Tags

Type your tag names separated by a space and hit enter

Reducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimer's disease, and Parkinson's disease.
Nutr Neurosci 2005; 8(2):67-89NN

Abstract

Mitochondrial decay due to oxidative damage is a contributor to brain aging and age-related neurodegenerative diseases, such as Alzheimer's disease (AD) and Parkinson's disease (PD). One type of mitochondrial decay is oxidative modification of key mitochondrial enzymes. Enzyme dysfunction, that is due to poor binding of substrates and coenzymes may be ameliorated by supplementing adequate levels of substrates or coenzyme precursors. Such supplementation with mitochondrial nutrients (mt-nutrients) may be useful to prevent or delay mitochondrial decay, thus prevent or treat AD and PD. In the present review, we survey the literature to identify mt-nutrients that can (1) protect mitochondrial enzymes and/or stimulate enzyme activity by elevating levels of substrates and cofactors; (2) induce phase-2 enzymes to enhance antioxidant defenses; (3) scavenge free radicals and prevent oxidant production in mitochondria, and (4) repair mitochondrial membrane. Then, we discuss the relationships among mt-nutrient deficiency, mitochondrial decay, and cognitive dysfunction, and summarize available evidence suggesting an effect of mt-nutrient supplementation on AD and PD. It appears that greater effects might be obtained by longer-term administration of combinations of mt-nutrients. Thus, optimal doses of combinations of mt-nutrients to delay and repair mitochondrial decay could be a strategy for preventing and treating cognitive dysfunction, including AD and PD.

Authors+Show Affiliations

Nutritional Genomic Center, Children's Hospital Oakland Research Institute, Oakland, CA 94609, USA. jliu@chori.orgNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Review

Language

eng

PubMed ID

16053240

Citation

Liu, Jiankang, and Bruce N. Ames. "Reducing Mitochondrial Decay With Mitochondrial Nutrients to Delay and Treat Cognitive Dysfunction, Alzheimer's Disease, and Parkinson's Disease." Nutritional Neuroscience, vol. 8, no. 2, 2005, pp. 67-89.
Liu J, Ames BN. Reducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimer's disease, and Parkinson's disease. Nutr Neurosci. 2005;8(2):67-89.
Liu, J., & Ames, B. N. (2005). Reducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimer's disease, and Parkinson's disease. Nutritional Neuroscience, 8(2), pp. 67-89.
Liu J, Ames BN. Reducing Mitochondrial Decay With Mitochondrial Nutrients to Delay and Treat Cognitive Dysfunction, Alzheimer's Disease, and Parkinson's Disease. Nutr Neurosci. 2005;8(2):67-89. PubMed PMID: 16053240.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Reducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimer's disease, and Parkinson's disease. AU - Liu,Jiankang, AU - Ames,Bruce N, PY - 2005/8/2/pubmed PY - 2005/9/13/medline PY - 2005/8/2/entrez SP - 67 EP - 89 JF - Nutritional neuroscience JO - Nutr Neurosci VL - 8 IS - 2 N2 - Mitochondrial decay due to oxidative damage is a contributor to brain aging and age-related neurodegenerative diseases, such as Alzheimer's disease (AD) and Parkinson's disease (PD). One type of mitochondrial decay is oxidative modification of key mitochondrial enzymes. Enzyme dysfunction, that is due to poor binding of substrates and coenzymes may be ameliorated by supplementing adequate levels of substrates or coenzyme precursors. Such supplementation with mitochondrial nutrients (mt-nutrients) may be useful to prevent or delay mitochondrial decay, thus prevent or treat AD and PD. In the present review, we survey the literature to identify mt-nutrients that can (1) protect mitochondrial enzymes and/or stimulate enzyme activity by elevating levels of substrates and cofactors; (2) induce phase-2 enzymes to enhance antioxidant defenses; (3) scavenge free radicals and prevent oxidant production in mitochondria, and (4) repair mitochondrial membrane. Then, we discuss the relationships among mt-nutrient deficiency, mitochondrial decay, and cognitive dysfunction, and summarize available evidence suggesting an effect of mt-nutrient supplementation on AD and PD. It appears that greater effects might be obtained by longer-term administration of combinations of mt-nutrients. Thus, optimal doses of combinations of mt-nutrients to delay and repair mitochondrial decay could be a strategy for preventing and treating cognitive dysfunction, including AD and PD. SN - 1028-415X UR - https://www.unboundmedicine.com/medline/citation/16053240/full_citation L2 - http://www.tandfonline.com/doi/full/10.1080/10284150500047161 DB - PRIME DP - Unbound Medicine ER -